Alpha Therapy Deep Dive: Q&A Session | Experts from CANM'23

The Future of Radiopharmaceuticals | Christopher P. Leamon | CANM'23

Isotope Production in Alpha Therapy | Paul Schaffer | CANM'23

Alpha Emitter Chemistry: CNL Insights | Svetlana Selivanova | CANM'23

Exploring Alpha Therapy: Advantages & Applications | Lionel Zuckier | CANM'23

Cardiac Imaging Q&A and Closing Remarks | Dr. Terry Ruddy | CANM'23

Myocardial Blood Flow: PET & SPECT Techniques | Glenn Wells | CANM'23

Training in Nuclear Cardiology & PET | Gary Small | Educational Insights CANM'23

Cardiac CT in a Multimodal World | Benjamin Chow | CANM'23

Cardiac Sarcoidosis: Nuclear Imaging Insights | Eugene Leung | CANM'23

Expert Q&A: Cardiac Nuclear Imaging | Canadian Assoc. of Nuclear Medicine Conference

Vasculitis & Molecular Imaging: Matthieu Pelletier Galarneau | Canadian Assoc. of Nuclear Medicine

PET in CAD: Perfusion & Flow Analysis | Thomas Schindler | Canadian Assoc. of Nuclear Medicine

Unraveling Amyloidosis Imaging: Cigdem Akincioglu | CAPER Initiative Insights

Digital SPECT & PET in Cardiology: Ronald G. Schwartz | Canadian Assoc. Of Nuclear Medicine

Contemporary Cardiac SPECT Explained | Prem Someone | Canadian Assoc. of Nuclear Medicine

Mastering the Art of Radioligand therapy

Advancing Nuclear Medicine Through Software | CANM x Hermes Medical Solutions Webinar

Theranostics V1 0 2 0 and 3 0 Challenges and Opportunities

Quantitative VQ SPECT Emerging Applications

FDG PET CT imaging of cardiovascular infections

Myocardial Blood Flow Quantitation with 18F-Flurpiridaz PET | CANM Annual Scientific Conference

PET CT Quantification of Myocardial Blood Flow with Rb 82 for CAD Diagnosis

NaF PET Bone Scintigraphy

Contemporary bone scintigraphy

Impact of COVID 19 on practice and performance in Nuclear Medicine

The Future of Nuclear Oncology for PSMA Theranostics

PSMA Theranostics for Prostate Cancer

Imaging, PSMA PET/CT cases (pre/post therapy)

FDG PET Imaging